Journal of Sports and Biomotor Sciences

Journal of Sports and Biomotor Sciences

Comparison of the effect of high intensity interval training and voluntary exercise in motor enriched environment on the expression of irisin and adiponectin proteins in the hippocampal tissue of rats with Alzheimer's disease

Authors
fatemeh Zaeri Irani
Mohammad reza Kordi
Reza Nuori
10.22034/sbs.2019.161221
Abstract
Introduction and purpose: Although the beneficial role of exercise in the health of patients with Alzheimer's (AD) has been reported, the mechanism of these effects on neuronal function in these patients is still not well understood. Therefore, the present study was designed to compare the effect of high intensity interval training (HIIT) and exercise in motor enriched environment (RE) on the expression of irisin and adiponectin proteins in the hippocampal tissue of Alzheimer's rats.
Material and Methods: In this experimental study, 25 rats were divided into (1) control, (2) sham (Sh), (3) streptozotocin Alzheimer's model (AD) (4) high intensity interval training (HIIT) and (5) Exercises in motor enriched environment (RE). The HIIT group trained for eight weeks, five sessions per week and each session in 90 seconds practice in 9interval with an intensity of 85% of maximum speed, and the RE group were placed in especially motor enriched cages. In order to confirm the Alzheimer's model, thioflavin staining was used. One-way ANOVA with Tukey’ s post-hoc test was used for data analysis (P≤0.05).
Results: The RE exercises significantly increased in irisin levels compared to the Alzheimer's group (P=0.0009), HIIT exercises resulted in no significant change in irisin levels. None of the training methods caused significant changes in adiponectin level (P>0.05).
Discussion and Conclusion: Activity in an enriched motor environment through the irisin mechanism has more desirable effects in reducing AD symptoms
Keywords
Key words: Alzheimer's disease
Hippocampus
high intensity interval training
Voluntary exercise
1. JL Kandimalla R., et al. Apo-Eε4 allele in conjunction with Aβ42 and tau in CSF: biomarker for Alzheimer’s disease. Current Alzheimer Research, 2011 ;8(2):187–96. 2. J Kandimalla R., et al. CSF ubiquitin as a specific biomarker in Alzheimer’s disease. Current Alzheimer Research, 2014;11(4):340–8. 3. Binukumar BK., et al. Protective Efficacy of coenzyme Q 10 against DDVP-Induced cognitive impairments and neurodegeneration in rats. Neurotoxicity Research. 2012;21(4):345–57. 4. Reddy PH., et al. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer’s disease: Implications to mitochondria-targeted antioxidant therapeutics. Biochimica et Biophysica Acta - Molecular Basis of Disease . 2012;1822(5):639–49. 5. Iqbal, K.; Grundke-Iqbal, I. Alzheimer’s disease, a multifactorial disorder seeking multitherapies. Alzheimer’s Dement. J. Alzheimer’s Association. 2010, 6, 420–424. 6. Ferreira, S.T.; Clarke, J.R.; Bomfim, T.R.; De Felice, F.G. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer’s disease. Alzheimer’s Dement. J. Alzheimer’s Association. 2014, 10, S76–S83. 7. Chen, Y.; Liang, Z.; Tian, Z.; Blanchard, J.; Dai, C.L.; Chalbot, S.; Iqbal, K.; Liu, F.; Gong, C.X. Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice. Molecular Neurobiology. 2014, 49, 547–562. 8. Hoyer S, Lannert H. Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tauprotein. Journal of Neural Transmission. Supplementa .2007; (72): 195- 202.

  • Receive Date 23 November 2022
  • Revise Date 27 February 2023